GlassScriptPhysician profile
Daniel Belew
NPI 1306229851
$15,697.64
in general payments reported to CMS, 2019-2025
54 companies · $1,949 in 2025
The $1,949 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,262 · 2020: $736 · 2021: $2,237 · 2022: $1,066 · 2023: $1,801 · 2024: $4,648 · 2025: $1,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,004 · Travel and Lodging: $2,358 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,004.13 |
| Travel and Lodging | $2,358.02 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,704.72 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Advance Xp |
| Edap Technomed INC | $1,911.00 | 2024 | |
| Coloplast Corp | $1,449.80 | 2019-2025 | |
| Angiodynamics, INC. | $1,435.20 | 2022-2025 | Nanoknife |
| Teleflex LLC | $1,160.09 | 2021-2025 | Barrigel, Urolift |
| Pfizer INC. | $377.55 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $330.81 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $330.08 | 2021-2025 | Lynparza, Imfinzi |
| Procept Biorobotics Corporation | $327.32 | 2023 | Aquabeam Robotic System |
| Axonics, INC. | $313.56 | 2020-2023 | Bulkamid, Axonics |
| Astellas Pharma US INC | $311.67 | 2021-2023 | Xtandi, Veozah |
| Merck Sharp & Dohme LLC | $286.08 | 2022-2025 | Keytruda, Welireg, Lynparza |
| I/O Urology Corp. | $277.66 | 2024 | Carepath |
| Abbvie INC. | $249.25 | 2019-2024 | Botox |
| Laborie Medical Technologies Corp. | $248.59 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Belew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.